COX-2/PGE2 pathway is involved in 1,25-dihydroxyvitamin D3-induced downregulation of CYP1B1 in breast cancer cell line MCF-7
10.3724/SP.J.1008.2012.00252
- Author:
Lei YUAN
1
Author Information
1. Department of Pathophysiology, Laboratory for Stem Cell and Tissue Engineering, Chongqing Medical University
- Publication Type:Journal Article
- Keywords:
1,25-dihydroxyvitamin D3;
Breast neoplasms;
Cyclooxygenase 2;
Cytochrome P450 1B1
- From:
Academic Journal of Second Military Medical University
2012;33(3):252-258
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the expressions of COX-2, p-ERα and CYP1B1 in human breast cancer tissues and ERα positive human breast cancer cell line MCF-7, and to investigate the influence of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] on proliferation, cell cycle transformation, and CYP1B1 protein expression in MCF-7 cells. Methods Immunohistochemical method was applied to examine the expressions of COX-2, p-ERα and CYP1B1 protein in 42 breast cancer tissues, and their association was analyzed. The effects of l,25(OH)2D3 on MCF-7 cell proliferation was investigated by MTT assay and the optimal concentration of l,25(OH)2D3 was determined for the following experiment. The cell cycle was analyzed by flow cytometry and COX-2 mRNA expression in MCF-7 cells was measured by RT-PCR. PGE2 level was detected by ELISA in the culture supernatant. The expression of COX-2, p-ERK, p-ERα and CYP1B1 protein was determined by Western blotting analysis and the distribution of COX-2, p-ERα and CYP1B1 expression in MCF-7 cells was examined by immune cell fluorescence. Results COX-2, p-ERα and CYP1B1 protein were positive in human breast cancer tissues and their expressions were positively correlated with each other(P<0. 05). l,25(OH)2D3 inhibited the proliferation of MCF-7 cells in a time- and dose-dependent manner (P<0. 05). Treatment with 100 nmol/L 1, 25 (OH)2 D3 for 72 h significantly arrested cell cycle in Go/Gi phase (P<0. 05), decreased the expression of COX-2 mRNA in MCF-7 cells (P<0. 05), decreased PGE2 level in the cell culture supernatant (P<0. 01), and down-regulated p-ERK, p-ERα and CYP1B1 protein expression(P<0. 05). Conclusion COX-2/PGE2 pathway plays a positive role in regulating CYP1B1 expression in breast cancer. 1,25(OH)2D3 may inhibit the growth of MCF-7 cells and down-regulate CYP1B1 through COX-2/PGE2 pathway.
